Technical Service Need help? Our team of experienced experts is here for you with full support.
AKA-138
Tabersonine
Cat. No.
AKA-138
CAS No.
4429-63-4
MF
C21H24N2O2
MW
336.42746
Tabersonine is a selective NLRP3 inhibitor.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Service 
86-28-85159085 
info@aktin.com Technical Data
Description
Documents
Storage and Shipping
References
Product Name
Tabersonine
CAS No.
4429-63-4
MF
C21H24N2O2
MW
336.42746
Specification
98%
Research Area
Intermediate
Description
Tabersonine is a selective NLRP3 inhibitor. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g, 1kg Availability: In Stock
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Zhang D, et al. Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination. Biochemical Pharmacology. 2018 Aug;154:183-192.
[2]. Li X, et al. Tabersonine Induces the Apoptosis of Human Hepatocellular Carcinoma In vitro and In vivo. Anti-cancer Agents in Medicinal Chemistry. 2024;24(10):764-772.
[3]. Xu HW, et al. Tabersonine, a natural NLRP3 inhibitor, suppresses inflammasome activation in macrophages and attenuate NLRP3-driven diseases in mice. Acta Pharmacologica Sinica. 2023 Jun;44(6):1252-1261.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
